Rippling v O'Brien and Others - Jurisdiction Challenge

The High Court of Ireland has issued a judgment concerning jurisdiction challenges in the case of Rippling v O'Brien and Others. The judgment addresses applications by defendants to set aside service of summons and dismiss claims for want of jurisdiction under the Brussels Regulation (Recast).

High Court Ireland Planning Case - Certificate to Appeal

The High Court of Ireland issued a judgment on March 20, 2026, in a planning case involving Jane Phelan Walsh and An Coimisiun Pleanala. The court is now considering an application for a certificate to appeal a previous judgment that granted an order of certiorari regarding a planning permission refusal.

E v International Protection Appeals Tribunal - Costs Ruling

The Supreme Court of Ireland has issued a ruling on costs concerning two cases, KE and FOM, related to international protection applications and the designation of the United Kingdom as a safe third country. The Court reversed a previous decision by the Court of Appeal regarding the mootness of the State parties' appeals due to legislative changes.

Wilson's Hospital School v Burke - Contempt of Court

The High Court of Ireland issued its fifth judgment concerning the ongoing contempt of court proceedings against Enoch Burke. This judgment addresses Mr. Burke's transfer from Mountjoy Prison to Castlerea Prison and his subsequent application regarding the conditions of his detention. The court treated a letter from his brother as Mr. Burke's application.

High Court Ireland: Social Protection and Employment Rights

The High Court of Ireland ruled on a case concerning social protection and employment rights for an undocumented Brazilian national. The court is reviewing a decision that denied redundancy payments due to the applicant's lack of a work permit, potentially conflicting with EU directives.

McAndrew-Bergson v Hennelly and Ors - Judicial Review

The High Court of Ireland has issued a judgment in the case of McAndrew-Bergson v Hennelly and Ors, concerning a judicial review. The applicant seeks an extension of time to bring a defamation action against a Consultant Psychiatrist and the Health Service Executive, related to alleged clinical mismanagement and defamation following her late husband's death.

Hoctor v An Coimisiun Pleanala - Planning and Environment Case

The High Court of Ireland has issued a judgment in the case of Hoctor v An Coimisiun Pleanala, concerning planning and environmental law. The court applied existing legal principles to the facts of a renewable energy project, dismissing the applicants' appeal.

People Centre Inc v O'Brien - Commercial Court Case

The High Court of Ireland issued a judgment in the case of People Centre Inc v O'Brien. The judgment addresses an application by the fourth defendant, Deel Inc, to strike out specific paragraphs of the plaintiffs' amended statement of claim, concerning allegations of trade secret misappropriation and covert conduct. The court's decision is part of a broader set of related judgments concerning jurisdiction and document production.

ACE Autobody Ltd v Motorpark Ltd & Ors - Costs Case

The Supreme Court of Ireland has issued a decision in the costs case ACE Autobody Ltd v Motorpark Ltd & Ors. The decision, identified as [2026] IESC 19, was approved and published on March 23, 2026.

ACE Autobody Ltd v Motorpark Ltd & Ors - Supreme Court of Ireland

The Supreme Court of Ireland has issued a ruling on costs in the case of ACE Autobody Ltd v Motorpark Ltd & Ors. The appeal, which concerned a property transaction and was dismissed in May 2025 due to inordinate and inexcusable delay, has now had its costs determined.

Friends of the Irish Environment v Minister for Environment - Climate Action Compliance

The Irish Court of Appeal has issued a judgment in a case concerning compliance with the Climate Action and Low Carbon Development Act 2015, as amended. The appeal, brought by Friends of the Irish Environment, challenges whether national actions taken to pursue a low-carbon economy comply with statutory requirements. The court acknowledges the critical importance of climate change but focuses on the legal and procedural aspects of the case.

Falkenthal v Revenue Commissioners - Tax Appeal Case

The Irish Court of Appeal has issued a judgment in the case of Falkenthal v Revenue Commissioners, concerning a tax appeal dating back to 1996/1997. The court upheld a High Court decision that affirmed the Revenue Commissioners' refusal to allow the appellant to pursue an appeal under certain provisions of the Taxes Consolidation Act 1997.

Linley Investments v Riley - Horse Boarding Fees Dispute

The Irish High Court has issued a judgment in a dispute between Linley Investments and Coolagown Bloodstock against Nigel Riley concerning unpaid fees for horse boarding and stud services. The court heard two related claims totaling over €336,000, with the defense filing a general denial.

People Centre Inc v O'Brien and Ors - Judgment No. 3

The High Court of Ireland issued Judgment No. 3 in the case of People Centre Inc v O'Brien and Ors. This judgment addresses an application by the fourth defendant, Deel Inc, concerning the production of documents, specifically a Termination Agreement. The parties have resolved issues related to redactions and the inspection of certain materials.

Yates v Dublin Bouldering Gym Ltd - Personal Injury

The High Court of Ireland has issued a judgment in the personal injury case of Yates v Dublin Bouldering Gym Ltd and The Royal College of Surgeons Ireland. The plaintiff sustained injuries on February 2, 2018, and claims damages for personal injury arising from alleged breaches of duty by the defendants.

USPTO Trademark Application for Primepet Looks AI Image Software

The USPTO has received an intent-to-use trademark application from Primepet Looks for AI image software. The application covers SaaS and downloadable software for generating, editing, and enhancing digital images, particularly of pets, using artificial intelligence.

5O. COM Trademark Application Published for Opposition

The USPTO has published the trademark application for '5O. COM' for opposition. The application, filed on March 22, 2026, covers a range of computing and electronics goods, including antennas, amplifiers, integrated circuits, and transceivers. This publication opens a period for third parties to oppose the registration.

USPTO Trademark Application: KADDY+ Disc Golf App

The USPTO has received an intent-to-use trademark application for 'KADDY+' for a downloadable mobile application related to disc golf. The application covers software for scoring, performance tracking, course mapping, and gameplay management.

USPTO Trademark Application Published for Opposition

The USPTO has published trademark application TM99717226 for CWG, which seeks to register downloadable electronic publications in the nature of e-books. The application was published for opposition on March 23, 2026, with a filing date of March 22, 2026.

Friction Health Trademark Application

The USPTO has received an intent-to-use trademark application from Friction Health for downloadable mobile applications related to habit tracking and digital wellness. The application was filed on March 22, 2026, with an intended effective date of March 23, 2026.

MARLOWE ENERGY-EFFICIENT Trademark Application

The USPTO has received an intent-to-use trademark application for 'MARLOWE ENERGY-EFFICIENT' filed on March 22, 2026. The application covers a broad range of services related to energy production, waste processing, financial recovery, engineering, software development, and educational services, all under the MARLOWE ENERGY-EFFICIENT brand and associated protocols.

USPTO Trademark Application Published for Opposition: CircumJovial

The USPTO has published the trademark application for 'CircumJovial' for opposition. The application covers home theater systems and computer programming services. The publication date is March 23, 2026.

USPTO Trademark Application Published for Opposition

The USPTO has published trademark application TM99717200 for opposition. The application seeks to register downloadable computer software for controlling audio and video devices. The publication date was March 23, 2026, with a filing date of March 22, 2026.

CALTRAX Trademark Application Filed

The USPTO has received an intent-to-use trademark application for the mark CALTRAX. The application covers downloadable mobile applications for retrieving and displaying health information. The filing date was March 22, 2026.

USPTO Trademark Application for TRUETABLE

The USPTO has received an intent-to-use trademark application for 'TRUETABLE' filed on March 23, 2026. The application covers downloadable computer software platforms for recipe selection, meal planning, recipe creation, and food/nutrition information.

KYNARE Trademark Publication for Opposition

The USPTO has published the trademark application for 'KYNARE' for opposition. The application covers goods including temperature sensors, cameras, and diving goggles. The publication date is March 23, 2026.

USPTO Trademark Application for CLIP2FLIP NFT Marketplace Software

The USPTO has received an intent-to-use trademark application for "CLIP2FLIP" software. This software is designed for creating and operating an online marketplace for goods authenticated by non-fungible tokens (NFTs). The application was filed on March 22, 2026.

USPTO Trademark Application: TINY TASKS

The USPTO has received an intent-to-use trademark application for the mark "TINY TASKS" filed on March 23, 2026. The application covers goods such as stickers, notebook paper, and magnets.

XINFORG trademark application published for opposition

XINFORG trademark application published for opposition

DAYSTEPS SAAS Trademark Application

The USPTO has received an intent-to-use trademark application from DAYSTEPS for SAAS services and downloadable software. The application covers software designed to assist individuals, including those with ADHD, autism, and executive function challenges, in managing daily routines and facilitating care coordination.

USPTO Trademark Application Published for Opposition

The USPTO has published a trademark application for opposition concerning downloadable software for tracking travel and visa compliance in the Schengen Area. The application was published on March 23, 2026, with a filing date of March 22, 2026.

GWTRONIC Intent to Use Trademark Application for Electronics

The USPTO has received an intent-to-use trademark application from GWTRONIC for various consumer electronic products. The application, filed on March 22, 2026, covers items such as audio amplifiers, speakers, cables, and power conversion devices.

22 OVER 7 Trademark Application for AI, Quantum, Robotics Software

The USPTO has received an intent-to-use trademark application from 22 OVER 7 for software related to disruptive technologies including AI, Quantum, and robotics. The application was filed on March 22, 2026, with an expected effective date of March 23, 2026.

Lureo Trademark Application - Dating and Social Networking Software

The USPTO has received an intent-to-use trademark application from Lureo for dating and social networking software. The application covers downloadable mobile applications and SaaS for connecting users based on geographic location. The filing date was March 22, 2026.

USPTO Trademark Application for Table Sniper Mobile App

The USPTO has received an intent-to-use trademark application for the mobile application 'Table Sniper'. The application covers downloadable software for monitoring restaurant reservation availability and alerting users to openings.

MORE VENUS Intent to Use Trademark Application

The USPTO has received an intent-to-use trademark application for the mark "MORE VENUS" filed on March 22, 2026. The application covers a range of goods and services including printed materials, apparel, digital content, and consulting services related to astrology and personal development.

USPTO Patent Grant for T Cell Antigen Receptor Complex

The USPTO has granted patent US12583910B2 to Tsinghua University for a T cell antigen receptor complex and its preparation method. This patent covers antibodies, T cell receptors, and immune cells designed to recognize pMHC complexes and activate T cells for therapeutic use.

USPTO Patent Grant: Antibody Inhibitors for Staphylococcus Aureus Treatment

The USPTO has granted patent US12583913B2 for antibody inhibitors targeting Staphylococcus aureus, specifically coagulases SC and vWbp. This patent covers therapeutic methods and detection techniques utilizing these monoclonal antibodies.

USPTO Patent Grant for Cancer Diagnosis using Anti-BAG2 Antibody

The USPTO has granted a patent (US12583915B2) to Medpacto, Inc. for methods of diagnosing cancer using an anti-BAG2 antibody. The patent covers compositions comprising antibodies that specifically bind to BAG2 polypeptides or fragments thereof.

USPTO Patent Grant for LRP6 Protein Binding Antibodies

The USPTO has granted a patent (US12583919B2) to Antlera Therapeutics Inc. for antibodies that specifically bind to LRP6 proteins and methods of their use. The patent was filed on August 14, 2020, and is set to be granted on March 24, 2026.

USPTO Patent Grant for Caged-Degron Molecular Feedback Circuits

The USPTO has granted patent US12583896B2 to The Regents of the University of California for caged-degron-based molecular feedback circuits. The patent covers methods of modulating signaling pathways in cells using these circuits, with a filing date of January 6, 2020.

USPTO Patent Grant: DNA-binding domain transactivators

The USPTO has granted a patent (US12583902B2) to the University of Massachusetts for DNA-binding domain transactivators and their uses. The patent covers recombinant adeno-associated viruses (rAAVs) designed to modify target gene expression in cells.

USPTO Patent Grant: Modified Plasma Clotting Factor VIII

The USPTO has granted patent US12583907B2 to AAVnerGene, INC. for modified human factor VIII polypeptides with enhanced activity. These polypeptides and their encoding viral vectors are intended for treating FVIII deficiencies, such as hemophilia A.

USPTO Patent US12583917B2: IL17A Antibodies for Veterinary Use

The USPTO has granted patent US12583917B2 to Elanco US Inc. for IL17A antibodies and antagonists intended for treating conditions in animals, including companion animals. The patent details specific antibody embodiments and IgG Fc variant polypeptides designed to reduce immune responses.

Mutant Myocilin Disease Model Patent Granted

The USPTO has granted Regeneron Pharmaceuticals, Inc. a patent (US12582104B2) for a mutant myocilin disease model. This patent covers non-human animal models engineered to express human myocilin, intended for assessing therapeutic reagents for glaucoma.

Amgen Inc. Patent for KRAS G12C Inhibitor Cancer Therapy

The USPTO has granted Amgen Inc. a patent (US12582657B2) for a combination therapy involving a KRAS G12C inhibitor and other agents for treating cancers. The patent covers pharmaceutical compositions and methods of treatment.

USPTO Patent Grant: RAS Oncoprotein Inhibitors

The USPTO has granted patent US12582660B2 to the University of Louisville Research Foundation, Inc. for inhibitors of the RAS oncoprotein, methods of making, and methods of use thereof. The patent covers compounds useful in treating diseases associated with activating mutations in RAS, particularly cancer.

USPTO Patent Granted for Anti-Pro/Latent Myostatin Antibodies

The USPTO has granted a patent (US12582712B2) to Scholar Rock, Inc. for a method of making anti-pro/latent myostatin antibodies. The patent covers antibodies that specifically bind proMyostatin and/or latent Myostatin and their uses.

USPTO Grants Patent for Anti-CD73 Antibody and Use

The United States Patent and Trademark Office (USPTO) has granted patent US12583933B2 to BIOTHEUS INC. for an anti-CD73 antibody and its use in enhancing immune response and treating tumors. The patent was filed on August 28, 2020, and is effective March 24, 2026.

USPTO Patent Grant for Tumor Diagnosis and Treatment

The USPTO has granted patent US12583937B2 to Genentech, Inc. for compositions and methods related to the diagnosis and treatment of tumors in mammals. The patent, filed on March 16, 2022, includes 6 claims.